tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OCS Stock Latest News

Oculis Publishes Invitation to the Annual General Meeting
Press ReleasesOculis Publishes Invitation to the Annual General Meeting
4d ago
OCS
Oculis price target lowered to $28 from $29 at H.C. Wainwright
PremiumThe Fly
Oculis price target lowered to $28 from $29 at H.C. Wainwright
10d ago
OCS
Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market
PremiumPress Releases
Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market
11d ago
OCS
Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market
PremiumPress Releases
Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market
11d ago
OCS
Oculis Announces Completion of Oversubscribed $59 Million Registered Direct Offering and Subsequent Listing on Nasdaq Iceland Main Market
PremiumPress Releases
Oculis Announces Completion of Oversubscribed $59 Million Registered Direct Offering and Subsequent Listing on Nasdaq Iceland Main Market
22d ago
OCS
Oculis announces listing on Nasdaq Iceland Main Market
PremiumThe FlyOculis announces listing on Nasdaq Iceland Main Market
22d ago
OCS
Oculis Strengthens its Executive Leadership Team with the Appointment of Snehal Shah, Pharm.D. as President of Research & Development
PremiumPress Releases
Oculis Strengthens its Executive Leadership Team with the Appointment of Snehal Shah, Pharm.D. as President of Research & Development
24d ago
OCS
Oculis names Dr. Snehal Shah as President of Research & Development
PremiumThe Fly
Oculis names Dr. Snehal Shah as President of Research & Development
24d ago
OCS
Positive Results from Phase 3 OPTIMIZE-1 Trial of Once Daily OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery Presented at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
PremiumPress Releases
Positive Results from Phase 3 OPTIMIZE-1 Trial of Once Daily OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery Presented at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
26d ago
OCS
Oculis announces ‘positive’ results from Phase 3 OPTIMIZE-1 trial of OCS-01
PremiumThe Fly
Oculis announces ‘positive’ results from Phase 3 OPTIMIZE-1 trial of OCS-01
26d ago
OCS
Oculis announces ‘positive’ results from Phase 3 OPTIMIZE-1 trial of OCS-01
PremiumThe Fly
Oculis announces ‘positive’ results from Phase 3 OPTIMIZE-1 trial of OCS-01
26d ago
OCS
Oculis to Participate at Upcoming April Investor Conferences
PremiumPress Releases
Oculis to Participate at Upcoming April Investor Conferences
30d ago
OCS
Oculis files $300M mixed securities shelf
PremiumThe FlyOculis files $300M mixed securities shelf
1M ago
OCS
Oculis Holding (NASDAQ:OCS): Riding on Bullish Expectations
PremiumMarket News
Oculis Holding (NASDAQ:OCS): Riding on Bullish Expectations
1M ago
OCS
Oculis price target lowered to $35 from $64 at Baird
PremiumThe Fly
Oculis price target lowered to $35 from $64 at Baird
2M ago
OCS
Oculis Reports Q4 and Full Year 2023 Financial Results and Update on Company Progress
PremiumPress Releases
Oculis Reports Q4 and Full Year 2023 Financial Results and Update on Company Progress
2M ago
OCS
Oculis provides update on progress of its late-stage clinical trials
PremiumThe Fly
Oculis provides update on progress of its late-stage clinical trials
2M ago
OCS
Oculis Provides Updates at R&D Day on Late-Stage Clinical Trials and Announces Key Leadership Appointments
PremiumPress Releases
Oculis Provides Updates at R&D Day on Late-Stage Clinical Trials and Announces Key Leadership Appointments
2M ago
OCS
Chardan lays out top 4 biotech picks for 2024
PremiumThe Fly
Chardan lays out top 4 biotech picks for 2024
3M ago
OCS
RNA
Oculis to Present at Upcoming February Investor Conferences
PremiumPress ReleasesOculis to Present at Upcoming February Investor Conferences
3M ago
OCS
Oculis to Host In-Person & Virtual R&D Day in New York on February 28, 2024
PremiumPress Releases
Oculis to Host In-Person & Virtual R&D Day in New York on February 28, 2024
3M ago
OCS
Oculis initiates second trial in ocular inflammation, pain, says H.C. Wainwright
PremiumThe Fly
Oculis initiates second trial in ocular inflammation, pain, says H.C. Wainwright
5M ago
OCS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >